Innovative Glycobiology Products ProZyme specializes in advanced glycan analysis reagents, kits, and standards, positioning it as a key provider for biopharmaceutical companies seeking high-quality tools for glycosylation profiling and biotherapeutic characterization.

Recent Product Launches The launch of high-throughput and automated glycan analysis systems like Gly-Q and GlykoPrep indicates ongoing innovation, offering sales opportunities for biopharma firms investing in efficiency and scalable glycosylation analysis solutions.

Strategic Acquisition Since being acquired by Agilent Technologies, ProZyme benefits from enhanced distribution channels, brand visibility, and integration with advanced analytical platforms, expanding market reach for existing and new product lines.

Market Focus Targeting biotherapeutic development and manufacturing sectors focused on quality and safety, offering tailored reagents and systems that help improve product consistency and regulatory compliance.

Growth Potential With an estimated revenue between $10M and $25M and a growing portfolio of innovative glycoanalysis tools, ProZyme presents opportunities for partnerships, volume sales, and expansion within the glycobiology research market.